Cargando…
The Need for Multi-Omics Biomarker Signatures in Precision Medicine
Recent advances in omics technologies have led to unprecedented efforts characterizing the molecular changes that underlie the development and progression of a wide array of complex human diseases, including cancer. As a result, multi-omics analyses—which take advantage of these technologies in geno...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6801754/ https://www.ncbi.nlm.nih.gov/pubmed/31561483 http://dx.doi.org/10.3390/ijms20194781 |